rapid7

Rapid7, Inc. (RPD) (Q1FY25) – Execution risk persists amid product transition and soft demand signals

Highlights of the report

The transition from traditional vulnerability management (VM) to a unified exposure management approach has not yet stabilized the performance of this product line.

CrispIdea equity reports provide valuable insights to investors who may be individuals and organizations involved in the world of finance and investment like private equity houses, broking firms, hedge funds, investment advisory firms, mutual funds, banks and corporations. This research report is useful for M&A, business & investment analysis to all students and researchers also.

 

CrispIdea equity reports include basic financials, strategic analysis, competitive landscape assessments, stock performance, stock analysis and future growth potential evaluation. CrispIdea utilizes a proprietary blend of fundamental and technical analysis, offering a unique perspective. Reports present clear investment recommendations (“BUY,” “HOLD,” or “SELL”).

 

Our established reputation and track record advocates that our research carries weight within the investment community. Do connect with us, if you are looking for customized research, equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Rapid7, Inc. provides cybersecurity solutions under the Rapid7, Nexpose, and Metasploit brand names

 Q1FY25 revenue of $210mn modestly exceeded guidance, supported by cost containment and expense timing rather than outsized revenue acceleration

The stock price showed an downward trend in the past 3-month period and gave -4% returns. The stock price fell by -32% in the past 1-year

 Executive Summary

• CrispIdea Forecast

– Income Statement

– Balance Sheet

– Cash Flow

– Common Size Ratio Analysis

– CrispIdea Segment Forecast

• Valuation & Historical Performance

– P/E Analysis

– CrispIdea Valuation

– Peer Comparison

– Ratio Analysis

– Economic Value-Added Analysis

– Du Pont Analysis

– CrispIdea Forecast Relative to Consensus

– Consensus Momentum

– Segment Performance

– Key Developments

– M&A Deals

• Ownership

• Stock Price Performance

• Crispidea Coverage

Report details

Rapid7, Inc. (RPD) (Q1FY25) – Execution risk persists amid product transition and soft demand signals

Price

$240.00

Company Reports

Sector Reports